ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

Scientist’s Interpretation Of Meta-Analysis On ESAs Turns 180 Degrees Over 72 Hours.

June 8, 2007

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

In Brief: Rod Heller Dead At 84; NCI Staff To Answer Questions About CCOP During ASCO Meeting

May 12, 1989

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009